All News

vaccination.jpg

CDC: Interim Guidance for COVID Vaccinated People

d Jack Cush, MD

Among 330 million Americans, roughly 32.1 million have been fully vaccinated and 61.1 million have received at least one dose of a COVID-19 vaccine (as of March 8th).

Read Article
colitis.jpg

Low IBD Risk with IL-17 Inhibition

d Jack Cush, MD

Incident or worsening colitis is a rare complication of IL-17 inhibitor therapy; a real world study confirms very low rates of new IBD in patients starting secukinumab.

Read Article
Lungs ILD

Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease

d Jack Cush, MD

Genentech announced Thursday that the US Food and Drug Administration approved tocilizumab (Actemra) for the treatment of Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), specifically indicated for slowing the rate of decline in pulmonary function in adul

Read Article
Swedish registry looked at odds of achieving remission with either Triple DMARD (347 MSH) or biologic Rx (1155) - more pts on biologics achieved remission at 1 yr (OR 1.79;1.18‐2.72) and 2 yrs (OR 1.92;1.21‐3.06). https://t.co/1MwhDbNxbf

Links:

Dr. John Cush RheumNow ( View Tweet)

Analysis of 8416 pts w/ Kawasaki disease (KD) shows older and younger children differ. <10% were under 6 mos, 78%) were 6 mos-4yrs; 11% 5 to 9 yrs. Younger KD had more incomplete KD, coronary aneurysms, while older had more delayed diagnoses, more fever https://t.co/NkSmfg38ru

Links:

Dr. John Cush RheumNow ( View Tweet)

The Reflecting Rheum: 2020 SpA and Still’s Disease Highlights Sponsored by Novartis Medical Affairs Listen to a discussion of medical experts share their views on the most impactful work done in spondyloarthritis and Still’s disease in 2020. https://t.co/rxTAwQNalx https://t.co/OEbHRn3gKP

Links:

Dr. John Cush RheumNow ( View Tweet)
Blinded by Noncompliance--New QD Clinic Suggestions on Optimizing Compliance in the Clinic https://t.co/tBnjBX68O8 https://t.co/uZ3aA7bnTJ

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Low IBD Risk with IL-17 Inhibition https://t.co/1kUH7sP755 https://t.co/DypPAcxB2a

Links:

Dr. John Cush RheumNow ( View Tweet)
Data Safety committee has closed recruitment to the colchicine arm in the RECOVERY trial a UK study of outcomes in COVID-19. Among 11162 enrolled pts (2178 deaths) those Rx w/ Colchicine had same 28 day mortality as usual care (20% vs. 19%) https://t.co/8gUc8LAZTp

Links:

Dr. John Cush RheumNow ( View Tweet)

Not surprisingly, a trial of repetitive transcranial magnetic stimulation failed to improve pain in fibromyalgia - next we can look forward to eye of newt N-of-1 trials. https://t.co/mEvvZhYgyR

Links:

Dr. John Cush RheumNow ( View Tweet)

We are just two weeks out from RheumNow Live. There's still time to register. Attend virtually or in-person. CME credits available. https://t.co/3zMtzt4t2H https://t.co/09Q5rRXsst

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Pounds of Prevention Dr. Jack Cush Reviews the news and journal reports from the past week on RheumNow. This podcast is sponsored by RheumNow Live. https://t.co/4XSBysiVFW https://t.co/PREqOkyuM9

Links:

Dr. John Cush RheumNow ( View Tweet)
Population study from Southern Norway shows the incidence of giant cell arteritis is not increasing. Over 13yrs, from pop of 300k they identified 206 GCA pts (72%females). Incidence rate of 16.8/100k per year. Mortality was not increased https://t.co/UA16uIuwD1

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - RA and LFTs NAFLD, NASH and Risks with DMARDs and MTX https://t.co/LYV9WycEjz https://t.co/CMGtU4vclY

Links:

Dr. John Cush RheumNow ( View Tweet)
#RA associated interstifial lung dz has incidence of 1-5 per 1,000 PYs and prevalence as high as 67%; risk factors; age, male sex, Dz duration, CCP Abs; w/ age as best predictor of mortality. There is no clear drug interventions that helps RA-ILD https://t.co/zJvWqt0w6L

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. Sign up to attend virtually or in-person today. https://t.co/SvLpwNYh9c

Links:

Dr. John Cush RheumNow ( View Tweet)

Why it's safe to come to RheumNow Live. Lessons learned from restaurants and flying. https://t.co/R0eYO2GiPd https://t.co/E9vPjzUTgb

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease https://t.co/6A4muejeH9 https://t.co/xQbIoEEscv

Links:

Dr. John Cush RheumNow ( View Tweet)
Download available--Difficult RA Defined https://t.co/6WGMEiwiUk

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow podcast now available! Listen on SoundCloud and Apple/Android podcasts. https://t.co/P6kaqZP0PJ https://t.co/BPQ5Ey7d0r

Links:

Dr. John Cush RheumNow ( View Tweet)
×